Marrow Transplantation for Hodgkin's Disease: Points to Ponder
- 1 January 1995
- journal article
- review article
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 15 (sup1) , 25-26
- https://doi.org/10.3109/10428199509052701
Abstract
(1995). Marrow Transplantation for Hodgkin's Disease: Points to Ponder. Leukemia & Lymphoma: Vol. 15, No. sup1, pp. 25-26.Keywords
This publication has 7 references indexed in Scilit:
- Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) as Adjunct Therapy in Relapsed Hodgkin DiseaseAnnals of Internal Medicine, 1992
- A numerical prognostic index for clinical use in identification of poor-risk patients with Hodgkin's disease at diagnosisEuropean Journal of Cancer and Clinical Oncology, 1991
- Prognostic factors among 185 adults with newly diagnosed advanced Hodgkin's disease treated with alternating potentially noncross-resistant chemotherapy and intermediate-dose radiation therapy.Journal of Clinical Oncology, 1990
- Treatment of progressive Hodgkin's disease with intensive chemoradiotherapy and autologous bone marrow transplantationBlood, 1989
- Prognostic factors for response and survival after high-dose cyclophosphamide, carmustine, and etoposide with autologous bone marrow transplantation for relapsed Hodgkin's disease.Journal of Clinical Oncology, 1989
- Successful treatment of refractory Hodgkin's disease by high-dose combination chemotherapy and autologous bone marrow transplantationBlood, 1989
- High-dose chemotherapy with autologous bone marrow transplantation in 50 advanced resistant Hodgkin's disease patients: an Italian study group report.Journal of Clinical Oncology, 1988